Varying sensitivity of human mammary carcinoma cells to the toxic effect of parvovirus H-1.
We have previously demonstrated lysis of non-established cultures of human mammary carcinoma cells by parvovirus H-1, which has little effect on the proliferation of corresponding normal cultures. In the present study, we examined this effect in a number of breast-tumour specimens and found them to differ as to the amplitude of their response to parvoviral attack. We first investigated whether the differences in cell sensitivity to parvovirus infection reflected the differentiation level of the initial tumour. Among the biochemical and anatomopathological indicators of original tumour differentiation, the presence of oestrogenic receptors (ER) was found to have a predictive value as to the sensitivity of derived cultures to the cytopathic effect of H-1 virus. The ER+ tumour-derived cultures showed an increased sensitivity to the lytic effect of H-1 virus compared with the ER-tumour-derived cultures, in spite of similar average proliferation rates for the two types of cultures. The proliferation rate was more heterogeneous among ER+ tumour-derived cultures and, in this group, the faster growing cultures were also the most sensitive. This observation was corroborated by the study of established cell lines retaining ER expression under in vitro culture conditions. Oestradiol was found to increase the sensitivity of these cells to the parvovirus in parallel with induction of proliferation. This effect appeared to be mediated by ER activation, since it was not observed in the ER-negative cell line MDA-MB-231. These data point to the importance of hormonal influences and cellular parameters, notably differentiation and proliferation, in determining the extent to which human cancer cells can be targets for the cytopathic effect of parvoviruses.
Van Pachterbeke
C
C
Laboratory of Biophysics and Radiobiology, Université Libre de Bruxelles, Belgium.
Tuynder
M
M
Brandenburger
A
A
Leclercq
G
G
Borras
M
M
Rommelaere
J
J
D001943:Breast Neoplasms / Q000737:chemistry / Q000150:complications* / Q000473:pathology*; D002454:Cell Differentiation / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D002470:Cell Survival / Q000502:physiology; D005260:Female; D006801:Humans; D010322:Parvoviridae Infections / Q000150:complications*; D017992:Parvovirus / Q000502:physiology*; D011960:Receptors, Estrogen / Q000032:analysis; D014407:Tumor Cells, Cultured
D011960:Receptors, Estrogen